High ALDHdim-expressing CD34+CD38- cells in leukapheresed peripheral blood is a reliable guide for a successful leukemic xenograft model of acute myeloid leukemia

Oncology Reports

Volumn 32, Issue 4, 2014, Pages 1638-1646

  Lee, Ji Yon ^a   Park, Sohye ^a   Han, A Reum ^a   Lim, Jihyang ^a   Min, Wo Sung ^a   Kim, He Je ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

Leukapheresed peripheral blood; Leukemic xenograft

Indexed keywords

ALDEHYDE DEHYDROGENASE; CD34 ANTIGEN; CD38 ANTIGEN;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CANCER STEM CELL; CELL POPULATION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; LEUKAPHERESIS; LEUKEMIC STEM CELL; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RELIABILITY; TUMOR ENGRAFTMENT; TUMOR XENOGRAFT; YOUNG ADULT; ACUTE MYELOBLASTIC LEUKEMIA; ANIMAL; CANCER TRANSPLANTATION; DISEASE MODEL; FLOW CYTOMETRY; METABOLISM; MONONUCLEAR CELL; SCID MOUSE; TRANSPLANTATION;

ADOLESCENT; ADULT; AGED; ALDEHYDE DEHYDROGENASE; ANIMALS; ANTIGENS, CD34; ANTIGENS, CD38; DISEASE MODELS, ANIMAL; FEMALE; FLOW CYTOMETRY; HUMANS; LEUKAPHERESIS; LEUKEMIA, MYELOID, ACUTE; LEUKOCYTES, MONONUCLEAR; MALE; MICE; MICE, SCID; MIDDLE AGED; NEOPLASM TRANSPLANTATION; NEOPLASTIC STEM CELLS; YOUNG ADULT;

EID: 84923068148     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2014.3359     Document Type: Article

References (28)

1. Gopinathan A and Tuveson DA: The use of GEM models for experimental cancer therapeutics. Dis Model Mech 1: 83-86, 2012.
2. Richmond A and Su Y: Mouse xenograft models vs GEM models for human cancer therapeutics. Dis Model Mech 1: 78-82, 2008.
3. Kelland LR: Of mice and men: values and liabilities of the athymic nude mouse model in anticancer drug development. Eur J Cancer 40: 827-836, 2004.
4. McCune JM, Namikawa R, Kaneshima H, Shultz LD, Lieberman M and Weissman IL: The SCID-hu mouse: murine model for the analysis of human hematolymphoid differentiation and function. Science 241: 1632-1639, 1988.
5. Mosier DE, Gulizia RJ, Baird SM and Wilson DB: Transfer of a functional human immune system to mice with severe combined immunodeficiency. Nature 335: 256-259, 1988.
6. Lubin I, Faktorowich Y, Lapidot T, Gan Y, Eshhar Z, Gazit E, et al: Engraftment and development of human T and B cells in mice after bone marrow transplantation. Science 252: 427-431, 1991. (Pubitemid 21916978)
7. Lapidot T, Pflumio F, Doedens M, Murdoch B, Williams DE and Dick JE: Cytokine stimulation of multilineage hematopoiesis from immature human cells engrafted in SCID mice. Science 255: 1137-1141, 1992.
8. Cheung AM, Wan TS, Leung JC, Chan LY, Huang H, Kwong YL, et al: Aldehyde dehydrogenase activity in leukemic blasts defines a subgroup of acute myeloid leukemia with adverse prognosis and superior NOD/SCID engrafting potential. Leukemia 21: 1423-1430, 2007. (Pubitemid 46965282)
9. Ishikawa F, Yasukawa M, Lyons B, Yoshida S, Miyamoto T, Yoshimoto G, et al: Development of functional human blood and immune systems in NOD/SCID/IL2 receptor {gamma} chain(null) mice. Blood 106: 1565-1573, 2005. (Pubitemid 41208567)
10. Ishikawa F, Yoshida S, Saito Y, Hijikata A, Kitamura H, Tanaka S, et al: Chemotherapy-resistant human AML stem cells home to and engraft within the bone-marrow endosteal region. Nat Biotechnol 25: 1315-1321, 2007. (Pubitemid 350076512)
11. Will B, Kawahara M, Luciano JP, Bruns I, Parekh S, Erickson-Miller CL, et al: Effect of the nonpeptide thrombopoietin receptor agonist Eltrombopag on bone marrow cells from patients with acute myeloid leukemia and myelodysplastic syndrome. Blood 114: 3899-3908, 2009.
12. Sanchez PV, Perry RL, Sarry JE, Perl AE, Murphy K, Swider CR, et al: A robust xenotransplantation model for acute myeloid leukemia. Leukemia 23: 2109-2117, 2009.
13. Goardon N, Marchi E, Atzberger A, Quek L, Schuh A, Soneji S, et al: Coexistence of LMPP-like and GMP-like leukemia stem cells in acute myeloid leukemia. Cancer Cell 19: 138-152, 2011.
14. Lapidot T, Sirard C, Vormoor J, Murdoch B, Hoang T, Caceres-Cortes J, et al: A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 367: 645-648, 1994. (Pubitemid 24067706)
15. Sarry JE, Murphy K, Perry R, Sanchez PV, Secreto A, Keefer C, et al: Human acute myelogenous leukemia stem cells are rare and heterogeneous when assayed in NOD/SCID/IL2Rγc-deficient mice. J Clin Invest 121: 384-395, 2011.
16. Gerber JM, Smith BD, Ngwang B, Zhang H, Vala MS, Morsberger L, et al: A clinically relevant population of leukemic CD34(+)CD38(-) cells in acute myeloid leukemia. Blood 119: 3571-3577, 2012.
17. Hong SH, Nah HY, Lee JY, Lee YJ, Lee JW, Gye MC, et al: Estrogen regulates the expression of the small proline-rich 2 gene family in the mouse uterus. Mol Cells 17: 477-484, 2004. (Pubitemid 39137108)
18. Lee JY, Park C, Cho YP, Lee E, Kim H, Kim P, et al : Podoplanin- expressing cells derived from bone marrow play a crucial role in postnatal lymphatic neovascularization. Circulation 122: 1413-1425, 2010.
19. Shultz LD, Ishikawa F and Greiner DL: Humanized mice in translational biomedical research. Nat Rev Immunol 7: 118-130, 2007. (Pubitemid 46174859)
20. Choi B, Chun E, Kim M, Kim SY, Kim ST, Yoon K, et al: Human T cell development in the liver of humanized NOD/SCID/ IL-2Rγ (null)(NSG) mice generated by intrahepatic injection of CD34(+) human (h) cord blood (CB) cells. Clin Immunol 139: 321-335, 2011.
21. c-null recipients. Blood 115: 3704-3707, 2010.
22. Lacombe F, Durrieu F, Briais A, Dumain P, Belloc F, Bascans E, et al: Flow cytometry CD45 gating for immunophenotyping of acute myeloid leukemia. Leukemia 11: 1878-1886, 1997. (Pubitemid 27485133)
23. Whartenby KA, Straley EE, Kim H, Racke F, Tanavde V, Gorski KS, et al: Transduction of donor hematopoietic stemprogenitor cells with Fas ligand enhanced short-term engraftment in a murine model of allogeneic bone marrow transplantation. Blood 100: 3147-3154, 2002. (Pubitemid 35217062)
24. Breems DA, van Hennik PB, Kusadasi N, Boudewijn A, Cornelissen JJ, Sonneveld P and Ploemacher RE: Individual stem cell quality in leukapheresis products is related to the number of mobilized stem cells. Blood 87: 5370-5378, 1996. (Pubitemid 26189879)
25. Zhang J, Yang WH, Yang XD, Shi ZX, Wang XL, Yu WJ, et al: Establishment and identification of CML model via injection of K562 cells into the murine caudal vein. Zhongguo Shi Yan Xue Ye Xue Za Zhi 20: 773-776, 2012 (In Chinese).
26. Park J, Kim KI, Koh Y, Won NH, Oh JM, Lee DS, et al: Establishment of a new Glivec-resistant chronic myeloid leukemia cell line, SNUCML-02, using an in vivo model. Exp Hematol 38: 773-781, 2010.
27. Lee J, Li M, Milwid J, Dunham J, Vinegoni C, Gorbatov R, et al: Implantable microenvironments to attract hematopoietic stem/cancer cells. Proc Natl Acad Sci USA 109: 19638-19643, 2012.
28. Elias AD, Ayash L, Anderson KC, Hunt M, Wheeler C, Schwartz G, et al: Mobilization of peripheral blood progenitor cells by chemotherapy and granulocyte-macrophage colonystimulating factor for hematologic support after high-dose intensification for breast cancer. Blood 79: 3036-3044, 1992.